Advertisement

Hemophilia Carrier Status and Counseling the Symptomatic and Asymptomatic Adolescent

      Abstract

      Carriers of hemophilia have a 50% chance of giving birth to a hemophilic son. Approximately 35% may have a lower than normal factor VIII or IX and therefore can be diagnosed without genetic testing. These individuals may present with menorrhagia, menometrorrhagia and dysmenorrhoea. The treatment of menorrhagia is similar to girls without bleeding disorders – tranexamic acid, the oral contraceptive pill and, where acceptable, the levonorgestrel-releasing intrauterine device. Genetic diagnosis is possible for potential carriers – 50% families with severe hemophilia carry the intron 22 inversion and databases are available which list most of the causative mutations for hemophilia A and B. Ideally the mutation in the index in a family is known. The testing of adolescents for a recessively inherited condition raises ethical issues and guidance may vary within different countries and cultures.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Pediatric and Adolescent Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rizza C.R.
        • Rhymes I.L.
        • Austen D.E.
        • et al.
        Detection of carriers of haemophilia: a ‘blind’ study.
        Br J Haematol. 1975; 30: 447
        • Lyon M.F.
        Sex chromatin and gene action in the mammalian X-chromosome.
        Am J Hum Genet. 1962; 14: 135
        • Astermark J.
        Genetic and environmental risk factors for inhibitor development.
        in: Lee C. Berntorp E. Hoots K. Textbook of Hemophilia. 2nd ed. Blackwell Publishing, London2010 (pp 57–61)
        • White 2nd, G.C.
        • Rosendaal F.
        • Aledort L.M.
        • et al.
        Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society of Thrombosis and Haemostasis.
        Thromb Haemost. 2001; 85: 560
        • Plug I.
        • Mauser-Bunschoten E.P.
        • Brocker-Vriends A.H.
        • et al.
        Bleeding in carriers of hemophilia.
        Blood. 2006; 108: 52
        • Antonarakis S.E.
        • Rossiter J.P.
        • Young M.
        • et al.
        Factor VIII gene inversions in severe hemophilia A: results of an international consortium study.
        Blood. 1995; 86: 2206
      1. Miller R: Genetic counseling for hemophilia WFH treatment monograph. World Federation of Hemophilia Publication. 2002; no. 25

        • Ludlam C.A.
        • Pasi K.J.
        • Bolton-Maggs P.
        • et al.
        A framework for genetic service provision for haemophilia and other inherited bleeding disorders.
        Haemophilia. 2005; 11: 145
        • Dunn N.F.
        • Miller R.
        • Griffioen A.
        • et al.
        Carrier testing in haemophilia A and B: adult carriers' and their partners' experience and their views on testing of young females.
        Haemophilia. 2008; 14: 584
      2. The United Nations Convention on the Rights of the Child (20. Xi. 1989: TS 44: Cm 1976)

      3. Gillick V: West Norfolk and Wisbech AHA (1986)

        • Santelli J.S.
        • Smith Rogers A.
        • Rosenfeld W.D.
        • et al.
        Guidelines for adolescent health research. A position paper of the Society for Adolescent Medicine.
        J Adolesc Health. 2003; 33: 396-409
        • Sanci L.
        • Sawyer S.M.
        • Weller P.J.
        • et al.
        Youth health research ethics: time for a mature-minor clause.
        Med J Aust. 2004; 180: 336
        • World Health Organization
        Proposed International Guidelines on Ethical Issues in Medical Genetics and Genetic Services.
        World Health Organization, Geneva1998
        • Clarke A.
        [chairman]: The genetic testing of children. Working Party of the Clinical Genetics Society (UK).
        J Med Genet. 1994; 31: 785
        • Nelson R.M.
        • Botkjin J.R.
        • Kodish E.D.
        • et al.
        Ethical issues with genetic testing.
        Pediatrics. 2001; 107: 1451
        • British Medical Association
        Consent, rights and choices in health care for children and young people.
        BMJ Books, London2005
        • James A.H.
        More than menorrhagia: a review of the obstetric and gynaecological manifestations of von Willebrand disease.
        Thromb Res. 2007; : S17
        • Kirtava A.
        • Drews C.
        • Lally C.
        • et al.
        Medical, reproductive and psychological experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case-control study.
        Hemophilia. 2003; 9: 292
        • James A.H.
        • Kouides P.A.
        • Abdul-Kadir R.
        • et al.
        Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel.
        Am J Obstet Gynecol. 2009; 201: 12.e1
        • Kingman C.E.
        • Kadir R.A.
        • Lee C.A.
        • et al.
        The use of levonorgestrel-releasing intrauterine system for the treatment of menorrhagia in women with inherited bleeding disorders.
        BJOG. 2004; 111: 1425